MTOR and breast cancer: The PI3K/Akt/mTOR pathway is involved in many cellular processes, including motility, growth, metabolism, and angiogenesis, and its abnormal activation often promotes BC growth and drug resistance (Shaw and Cantley, 2006; Courtney et al., 2010; Xie et al., 2022).